The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Antimicrobial Resistance Mechanisms among Campylobacter
Open accessAbstract
Campylobacter jejuni and Campylobacter coli are recognized as the most common causative agents of bacterial gastroenteritis in the world. Humans most often become infected by ingesting contaminated food, especially undercooked chicken, but also other sources of bacteria have been described. Campylobacteriosis is normally a self-limiting disease. Antimicrobial treatment is needed only in patients with more severe disease and in those who are immunologically compromised. The most common antimicrobial agents used in the treatment of Campylobacter infections are macrolides, such as erythromycin, and fluoroquinolones, such as ciprofloxacin. Tetracyclines have been suggested as an alternative choice in the treatment of clinical campylobacteriosis but in practice are not often used. However, during the past few decades an increasing number of resistant Campylobacter isolates have developed resistance to fluoroquinolones and other antimicrobials such as macrolides, aminoglycosides, and beta-lactams. Trends in antimicrobial resistance have shown a clear correlation between use of antibiotics in the veterinary medicine and animal production and resistant isolates of Campylobacter in humans. In this review, the patterns of emerging resistance to the antimicrobial agents useful in treatment of the disease are presented and the mechanisms of resistance to these drugs in Campylobacter are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences
Parkhill, J., Wren, B. W., Mungall, K., Ketley, J. M., Churcher, C., Basham, D., Chillingworth, T., Davies, R. M., Feltwell, T., Holroyd, S., et al. (2000) · Nature · doi:10.1038/35001088 · Cited by 1,976
Campylobacter jejuni Infections: Update on Emerging Issues and Trends
Acheson, D., & Allos, B. M. (2001) · Clinical Infectious Diseases · doi:10.1086/319760 · Cited by 1,216
Schlünzen, F., Zarivach, R., Harms, J., Bashan, A., Tocilj, A., Albrecht, R., Yonath, A., & Franceschi, F. (2001) · Nature · doi:10.1038/35101544 · Cited by 1,059
Experimental Campylobacter jejuni Infection in Humans
Black, R. E., Levine, M. M., Clements, M. L., Hughes, T. P., & Blaser, M. J. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/157.3.472 · Cited by 1,044
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
Experimental Campylobacter Jejuni Infection in Humans
Black, R. E., Levine, M. M., Clements, M. L., Hughes, T. P., & Blaser, M. J. (1988) · doi:10.21236/ada265410 · Cited by 869
Molecular basis of bacterial resistance to chloramphenicol and florfenicol
Schwarz, S., Kehrenberg, C., Doublet, B., & Cloeckaert, A. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.04.001 · Cited by 800
Engberg, J., Aarestrup, F. M., Taylor, D. E., Gerner-Smidt, P., & Nachamkin, I. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010104 · Cited by 696
The bacterial ribosome as a target for antibiotics
Poehlsgaard, J., & Douthwaite, S. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1265 · Cited by 607
Endtz, H. P., Ruijs, G. J., van Klingeren, B., Jansen, W. H., van der Reyden, T., & Mouton, R. P. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.2.199 · Cited by 590
Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria.
Khachatourians, G. G. (1998) · Europe PMC (PubMed Central) · Cited by 579
Fouts, D. E., Mongodin, E. F., Mandrell, R. E., Miller, W. G., Rasko, D. A., Ravel, J., Brinkac, L. M., DeBoy, R. T., Parker, C. T., Daugherty, S. C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030015 · Cited by 542
The β-lactamases of Gram-negative bacteria and their rôle in resistance to β-lactam antibiotics
Sykes, R. B., & Matthew, M. (1976) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/2.2.115 · Cited by 536
Antibiotic Resistance in Campylobacter : Emergence, Transmission and Persistence
Luangtongkum, T., Jeon, B., Han, J., Plummer, P., Logue, C. M., & Zhang, Q. (2009) · Future Microbiology · doi:10.2217/17460913.4.2.189 · Cited by 535
CmeABC Functions as a Multidrug Efflux System in Campylobacter jejuni
Lin, J., Michel, L. O., & Zhang, Q. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2124-2131.2002 · Cited by 528
Ribosomal Protection Proteins and Their Mechanism ofTetracyclineResistance
Connell, S. R., Tracz, D. M., Nierhaus, K. H., & Taylor, D. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3675-3681.2003 · Cited by 449
Infective dose of Campylobacter jejuni in milk.
Robinson, D. A. (1981) · BMJ · doi:10.1136/bmj.282.6276.1584 · Cited by 409
Involvement of a Plasmid in Virulence of Campylobacter jejuni 81-176
Bacon, D. J., Alm, R. A., Burr, D. H., Hu, L., Kopecko, D. J., Ewing, C. P., Trust, T. J., & Guerry, P. (2000) · Infection and Immunity · doi:10.1128/iai.68.8.4384-4390.2000 · Cited by 384
Trends in Antibiotic Resistance Among Diarrheal Pathogens Isolated in Thailand Over 15 Years
Hoge, C. W., Gambel, J. M., Srijan, A., Pitarangsi, C., & Echeverria, P. (1998) · Clinical Infectious Diseases · doi:10.1086/516303 · Cited by 375
Molecular understanding of aminoglycoside action and resistance
Jana, S., & Deb, J. K. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0279-0 · Cited by 336
Lin, J., Sahin, O., Michel, L. O., & Zhang, Q. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4250-4259.2003 · Cited by 308
Wang, Y., Huang, W. M., & Taylor, D. E. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.457 · Cited by 280
Wang, Y., & Taylor, D. E. (1990) · Gene · doi:10.1016/0378-1119(90)90463-2 · Cited by 273
Trowell, H. C. (1974) · The Lancet · Cited by 259
Luo, N., Sahin, O., Lin, J., Michel, L. O., & Zhang, Q. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.390-394.2003 · Cited by 251
Ruiz-Palacios, G. M. (2007) · Clinical Infectious Diseases · doi:10.1086/509936 · Cited by 238
Campylobacter Bacteremia: Clinical Features and Factors Associated with Fatal Outcome
Pacanowski, J., Lalande, V., Lacombe, K., Boudraa, C., Lesprit, P., Legrand, P., Trystram, D., Kassis, N., Arlet, G., Mainardi, J., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/591530 · Cited by 209
Incidence of Guillain-Barré Syndrome following Infection with Campylobacter jejuni
McCarthy, N., & Giesecke, J. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.6.610 · Cited by 202
Campylobacter Reactive Arthritis: A Systematic Review
Pope, J. E., Krizova, A., Garg, A. X., Thiessen-Philbrook, H., & Ouimet, J. M. (2007) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.12.006 · Cited by 199
McDermott, P. F., Bodeis, S. M., English, L. L., White, D. G., Walker, R. D., Zhao, S., Simjee, S., & Wagner, D. D. (2002) · The Journal of Infectious Diseases · doi:10.1086/339195 · Cited by 194
Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp.
Payot, S., Bolla, J.-M., Corcoran, D., Fanning, S., Mégraud, F., & Zhang, Q. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.12.032 · Cited by 192
Lin, J., Akiba, M., Sahin, O., & Zhang, Q. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1067-1075.2005 · Cited by 190
Quinolone-resistant Campylobacter Infections: Risk Factors and Clinical Consequences1
Engberg, J., Neimann, J., Nielsen, E. M., Aarestrup, F. M., & Fussing, V. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1006.030669 · Cited by 179
Mechanisms of antibiotic resistance in Campylobacter species
Taylor, D. E., & Courvalin, P. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1107 · Cited by 178
Antimicrobial resistance of thermophilic Campylobacter
Aarestrup, F. M., & Engberg, J. (2001) · Veterinary Research · doi:10.1051/vetres:2001127 · Cited by 177
Clinical Aspects of Campylobacter jejuni and Campylobacter coli Infections
Blaser, M. J., & Engberg, J. (2014) · Campylobacter · doi:10.1128/9781555815554.ch6 · Cited by 176
Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump
Pumbwe, L. (2002) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00532-8 · Cited by 175
Gibreel, A., Kos, V. N., Keelan, M., Trieber, C. A., Lévesque, S., Michaud, S., & Taylor, D. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2753-2759.2005 · Cited by 175
Comparative Antibiotic Resistance of Diarrheal Pathogens from Vietnam and Thailand, 1996-1999
Isenbarger, D. W., Hoge, C. W., Srijan, A., Pitarangsi, C., Vithayasai, N., Bodhidatta, L., Hickey, K. W., & Cam, P. D. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0802.010145 · Cited by 174
Llano-Sotelo, B., Azucena, E. F., Kotra, L. P., Mobashery, S., & Chow, C. S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00125-4 · Cited by 167
Gibreel, A., Tracz, D. M., Nonaka, L., Ngo, T. M., Connell, S. R., & Taylor, D. E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3442-3450.2004 · Cited by 164
Generation of Campylobacter jejuni genetic diversity in vivo
Boer, P. D., Wagenaar, J. A., Achterberg, R. P., Putten, J. P. M. V., Schouls, L. M., & Duim, B. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02930.x · Cited by 159
Batchelor, R. A., Pearson, B. M., Friis, L. M., Guerry, P., & Wells, J. M. (2004) · Microbiology · doi:10.1099/mic.0.27112-0 · Cited by 155
Ge, B., McDermott, P. F., White, D. G., & Meng, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3347-3354.2005 · Cited by 150
Increasing Fluoroquinolone Resistance inCampylobacter jejuni,Pennsylvania, USA,1982–20011
Nachamkin, I., Ung, H., & Li, M. (2002) · Emerging infectious diseases · doi:10.3201/eid0812.020115 · Cited by 144
Akiba, M., Lin, J., Barton, Y.-W., & Zhang, Q. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki419 · Cited by 141
COHORT STUDY OF INTESTINAL INFECTION WITH CAMPYLOBACTER IN MEXICAN CHILDREN
Calva, J. J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91297-4 · Cited by 138
Griggs, D. J., Johnson, M. M., Frost, J. A., Humphrey, T., Jorgensen, F., & Piddock, L. J. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.699-707.2005 · Cited by 131
Mechanism of Tet(O)‐mediated tetracycline resistance
Connell, S. R., Trieber, C. A., Dinos, G. P., Einfeldt, E., Taylor, D. E., & Nierhaus, K. H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg093 · Cited by 127 · cited 1×
“Furthermore, the conformational change persists for an extended period of time, thus allowing for continued protein elongation in an efficient manner [38, 44].”
BackgroundKey Role of Mfd in the Development of Fluoroquinolone Resistance in Campylobacter jejuni
Han, J., Şahin, O., Barton, Y.-W., & Zhang, Q. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000083 · Cited by 124
Tam, C. C., Rodrigues, L. C., Petersen, I., Islam, A., Hayward, A. C., & O’Brien, S. J. (2006) · The Journal of Infectious Diseases · doi:10.1086/504294 · Cited by 122
Rautelin, H. I. K., Renkonen, O. V., & Kosunen, T. U. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.10.2065 · Cited by 121
Bae, W., Kaya, K., Hancock, D. D., Call, D. R., Park, Y. H., & Besser, T. E. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.1.169-174.2005 · Cited by 121
Humphrey, T. J., Jorgensen, F., Frost, J. A., Wadda, H., Domingue, G., Elviss, N. C., Griggs, D. J., & Piddock, L. J. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.690-698.2005 · Cited by 120
Effect of Macrolide Usage on Emergence of Erythromycin-Resistant Campylobacter Isolates in Chickens
Lin, J., Yan, M., Şahin, O., Pereira, S., Chang, Y., & Zhang, Q. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01411-06 · Cited by 119
Payot, S., Avrain, L., Magras, C., Praud, K., Cloeckaert, A., & Chaslus-Dancla, E. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.008 · Cited by 114
Cagliero, C., Mouline, C., Cloeckaert, A., & Payot, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00616-06 · Cited by 110
Avrain, L., Vernozy‐Rozand, C., & Kempf, I. (2004) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02306.x · Cited by 105
Yan, M., Şahin, O., Lin, J., & Zhang, Q. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl412 · Cited by 105
Tetracycline resistance of Australian Campylobacter jejuni and Campylobacter coli isolates
Pratt, A., & Korolik, V. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki040 · Cited by 99
Inglis, G. D., McAllister, T. A., Busz, H. W., Yanke, L. J., Morck, D. W., Olson, M. S., & Read, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.7.3872-3881.2005 · Cited by 98
Fitness of antimicrobial-resistant Campylobacter and Salmonella
Zhang, Q., Şahin, O., McDermott, P. F., & Payot, S. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.12.031 · Cited by 95
Reina, J., Ros, M. J., & Serra, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.12.2917 · Cited by 95
Campylobacter species and drug resistance in a north Indian rural community
Jain, D. K., Sinha, S., Prasad, K. N., & Pandey, C. M. (2004) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2004.09.006 · Cited by 90
Hakanen, A., Jousimies-Somer, H. R., Siitonen, A., Huovinen, P., & Kotilainen, P. (2003) · Emerging infectious diseases · doi:10.3201/eid0902.020227 · Cited by 89
Pumbwe, L. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh331 · Cited by 88
pVir and Bloody Diarrhea inCampylobacter jejuniEnteritis
Tracz, D. M., Keelan, M., Ahmed-Bentley, J., Gibreel, A., Kowalewska‐Grochowska, K., & Taylor, D. E. (2005) · Emerging infectious diseases · doi:10.3201/eid1106.041052 · Cited by 87
Taylor, D. E., Garner, R. S., & Allan, B. J. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.6.930 · Cited by 87
Development, Stability, and Molecular Mechanisms of Macrolide Resistance in Campylobacter jejuni
Caldwell, D. B., Wang, Y., & Lin, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00450-08 · Cited by 86
Gibreel, A., Wetsch, N. M., & Taylor, D. E. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01592-06 · Cited by 83
Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli
Cagliero, C., Mouline, C., Payot, S., & Cloeckaert, A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki292 · Cited by 83
van Boven, M., Veldman, K. T., de Jong, M. C. M., & Mevius, D. J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg402 · Cited by 83
Antibiotics acting on the translational machinery
Harms, J., Bartels, H., Schlünzen, F., & Yonath, A. (2003) · Journal of Cell Science · doi:10.1242/jcs.00365 · Cited by 73
Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli
Barros‐Velázquez, J., Jimenez, A., Chomón, B., & Villa, T. G. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.1.173 · Cited by 69
Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia
UNICOMB, L. E., Ferguson, J., Riley, T. V., & Collignon, P. (2003) · Emerging infectious diseases · doi:10.3201/eid0911.030336 · Cited by 69
Mosaic Structure of a Multiple-Drug-Resistant, Conjugative Plasmid from Campylobacter jejuni
Nirdnoy, W., Mason, C. J., & Guerry, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2454-2459.2005 · Cited by 68
Variation of the natural transformation frequency of Campylobacter jejuni in liquid shake culture
Wilson, D. L., Bell, J. A., Young, V. B., WILDER, S. R., Mansfield, L. S., & Linz, J. E. (2003) · Microbiology · doi:10.1099/mic.0.26531-0 · Cited by 68
Adler-Mosca, H., Lüthy-Hottenstein, J., Lucchini, G. M., et al. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02005451 · Cited by 65
[37] Systems of experimental genetics for Campylobacter species
Guerry, P., Yao, R., Alm, R. A., et al. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)35163-5 · Cited by 61
Evidence for Multiple-Antibiotic Resistance in Campylobacter jejuni Not Mediated by CmeB or CmeF
Pumbwe, L., Randall, L. P., Woodward, M. J., & Piddock, L. J. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1289-1293.2005 · Cited by 59
Delsol, A. A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh150 · Cited by 58
Modes of Antimicrobial Action and Mechanisms of Bacterial Resistance
Guardabassi, L., & Courvalin, P. M. (2019) · ASM Press eBooks · doi:10.1128/9781555817534.ch1 · Cited by 56
Hariharan, H., Sharma, S., Chikweto, A., Matthew, V., & DeAllie, C. (2008) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2008.01.010 · Cited by 55
Vlieghe, E., Jacobs, J. A., Esbroeck, M. V., Koole, O., & Gompel, A. V. (2008) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2008.00236.x · Cited by 53
Tenover, F. C., Gilbert, T., & O’Hara, P. J. (1989) · Plasmid · doi:10.1016/0147-619x(89)90035-8 · Cited by 50
Bester, L. A., & Essack, S. Y. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn408 · Cited by 48
Kim, J., Carver, D. K., & Kathariou, S. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.2.1316-1321.2006 · Cited by 48
Tribble, D. R., Baqar, S., Carmolli, M. P., Porter, C. K., Pierce, K. K., Sadigh, K. S., Guerry, P., Larsson, C. J., Rockabrand, D., Ventone, C. H., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/644622 · Cited by 47
Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients
Sjögren, E. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.2.257 · Cited by 45
Mode of Action of the Tetracyclines and the Nature of Bacterial Resistance to Them
Chopra, I. (1985) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-70304-1_6 · Cited by 44
Skjøt-Rasmussen, L., Ethelberg, S., Emborg, H., Agersø, Y., Larsen, L. S., Nordentoft, S., Olsen, S. S., Ejlertsen, T., Holt, H. M., Nielsen, E. M., et al. (2009) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2009.03.006 · Cited by 41
Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea
Ruiz, J., Marco, F., OLIVEIRA, I., Vilà, J., & Gascón, J. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_567.x · Cited by 36
Transmission of Antibiotic Resistance from Food Animals to Humans
Aarestrup, F. M., McDermott, P. F., & Wegener, H. C. (2014) · ASM Press eBooks · doi:10.1128/9781555815554.ch36 · Cited by 30
Molecular characterization of class 1 integrons from Irish thermophilic Campylobacter spp.
O’Halloran, F. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh193 · Cited by 30
Cagliero, C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl212 · Cited by 30
Schönberg-Norio, D., Hänninen, M., Katila, M., Kaukoranta, S.-S., Koskela, M., Eerola, E., Uksila, J., Pajarre, S., & Rautelin, H. I. K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1086-1088.2006 · Cited by 29
Tenover, F. C., Fennell, C. L., Lee, L., & LeBlanc, D. J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.712 · Cited by 21
Increasing rates of ciprofloxacin resistant campylobacter.
Sam, W., Lyons, M. M., & Waghorn, D. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.9.709 · Cited by 20
Antimicrobial Resistance in Campylobacter
Engberg, J., Keelan, M., Gerner‐Smidt, P., & Taylor, D. E. (2019) · ASM Press eBooks · doi:10.1128/9781555817534.ch16 · Cited by 17
Genetic characterization of kanamycin resistance in Campylobacter coli
Taylor, D. E., Yan, W., Ng, L. ‐., Manavathu, E. K., & Courvalin, P. M. (1988) · Research in Microbiology · doi:10.1016/0769-2609(88)90071-3 · Cited by 17
Woźniak-Biel, A. (2011) · Cited by 10
Cited by
Global Epidemiology of Campylobacter Infection
Kaakoush, N. O., Castaño-Rodríguez, N., Mitchell, H. M., & Man, S. M. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-15 · Cited by 1,529
Chlebicz, A., & Śliżewska, K. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15050863 · Cited by 542
Campylobacteriosis: the role of poultry meat
Skarp, C. P. A., Hänninen, M.-L., & Rautelin, H. I. K. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.11.019 · Cited by 433
Shariati, A., Arshadi, M., Khosrojerdi, M. A., Abedinzadeh, M., Ganjalishahi, M., Maleki, A., Heidary, M., & Khoshnood, S. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1025633 · Cited by 337
Human campylobacteriosis: A public health concern of global importance
Igwaran, A., & Okoh, A. I. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02814 · Cited by 332
Metadata
- Authors
- Wieczorek, K., & Osek, J.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-12
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W1977184995
- Cited by
- 296
- References
- 104
- FWCI
- 21.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.